Centinel Spine announced that it entered into a definitive agreement to sell its global spine fusion product portfolio to Silony Medical.
The companies expect the transaction to close within 45 days. The companies declined to disclose the terms of the divestiture of the portfolio and related assets.
West Chester, Pennsylvania–based Centinel Spine says the sale enables it to focus exclusively on its Prodisc total disc replacement (TDR) platform. The company aims to become the global market leader in cervical and lumbar total disc replacement. Its 2022 Prodisc revenue neared $45 million, taking the company to the second spot in the global market, it said.
Centinel Spine reports first-half, year-over-year Prodisc revenue growth of more than 50% in 2023. It attributed some growth to the September launch of the Prodisc C Vivo and Prodisc C SK systems. The divestiture sees Centinel Spine’s Stalif products move to Silony.
“This divestiture al…